Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)
China · Delayed Price · Currency is CNY 15.01
+0.17 (1.15%)
At close: Jan 23, 2026
Shenzhen YHLO Biotech Market Cap
Shenzhen YHLO Biotech has a market cap or net worth of 8.58 billion as of January 23, 2026. Its market cap has decreased by -8.91% in one year.
Market Cap
8.58B
Enterprise Value
8.87B
Revenue
1.90B
Ranking
n/a
PE Ratio
57.56
Stock Price
15.01
Market Cap Chart
Since May 17, 2021, Shenzhen YHLO Biotech's market cap has decreased from 25.92B to 8.58B, a decrease of -66.91%. That is a compound annual growth rate of -21.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 8.58B | 5.70% |
| Dec 31, 2025 | 8.11B | -9.95% |
| Dec 31, 2024 | 9.01B | -30.65% |
| Dec 29, 2023 | 12.99B | 16.62% |
| Dec 30, 2022 | 11.14B | -20.38% |
| Dec 31, 2021 | 13.99B | -46.02% |
| May 17, 2021 | 25.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cofoe Medical Technology | 11.47B |
| Qingdao Haier Biomedical Co.,Ltd | 10.83B |
| Sinocare | 10.39B |
| Guangzhou Wondfo Biotech Co.,Ltd | 10.22B |
| Shinva Medical Instrument | 10.16B |
| Sino Medical Sciences Technology | 9.98B |
| HOB Biotech Group Corp.,Ltd | 9.42B |
| INKON Life Technology | 9.01B |